Altos bursts out of stealth with $3B, a dream team C-suite and a wildly ambitious plan to reverse disease
Altos bursts out of stealth with $3B, a dream team [...]
Barron quits GSK to take CEO post at $3B biotech startup, leaving Wood to finish what he began
Barron quits GSK to take CEO post at $3B biotech [...]
Eli Lilly lines up metabolic pacts with Evotec, Abbisko as it awaits diabetes med nod from FDA
Eli Lilly lines up metabolic pacts with Evotec, Abbisko as [...]
With $825M SPAC merger, ProKidney sets stage for phase 3 trial of kidney disease cell therapy
With $825M SPAC merger, ProKidney sets stage for phase 3 [...]
Rewind: Roche returns to phase 2 after seeing post hoc signal in failed pivotal Huntington’s trial
Rewind: Roche returns to phase 2 after seeing post hoc [...]
‘Shots on goal’ to ‘deterministic’ drug development: Flagship CEO, Moderna Chair Noubar Afeyan pens first annual letter
‘Shots on goal’ to ‘deterministic’ drug development: Flagship CEO, Moderna [...]
‘Shots on goal’ to ‘deterministic’ drug development: Flagship CEO, Moderna Chair Afeyan pens first annual letter
‘Shots on goal’ to ‘deterministic’ drug development: Flagship CEO, Moderna [...]
FDA approval, global partnership on the agenda at Mithra as phase 3 menopause trials hit goals—with one blemish
FDA approval, global partnership on the agenda at Mithra as [...]
EMA sets out plan to accelerate clinical trials, reduce administrative burden
EMA sets out plan to accelerate clinical trials, reduce administrative [...]
FDA denies Denali’s Takeda-partnered Alzheimer’s drug from entering clinic
FDA denies Denali’s Takeda-partnered Alzheimer’s drug from entering clinic klahucik [...]